Physician

Malarvizhi Natarajan, MD

According to 2025 Medicare claims, Malarvizhi Natarajan, MD (NPI: 1306022868) practices rheumatology in the Lafayette-West Lafayette, IN market, with the plurality of this provider's patient population coming from Tippecanoe, IN. This provider's primary affiliated billing organization is ARNETT CLINIC, LLC (NPI: 1164490843; TIN: 352030653) and primary practice location at 47904-3055. Natarajan is affiliated with the Franciscan ACO, Inc. (ACO ID: A2550), Ascension Care Management (ACO ID: A2600), IRCCO (ACO ID: A2619), Main Street Rural Health Cedar ACO LLC (ACO ID: A5502), and Indiana University Health ACO, Inc. (ACO ID: D0034), participating under both the MSSP and REACH models.

Natarajan's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 682 traditional Medicare patients, billed 6,118 HCPCS/CPT codes, and received $184,452 in Medicare payments. The top billing code was 90677 (Pneumococcal conjugate vaccine, 20 valent (pcv20), for intramuscular use). Part D data shows 4,178 prescription claims across 688 beneficiaries totaling $3,972,210 in drug costs, led by Enbrel Sureclick (Etanercept). 2017 DME data shows 14 claims. Open Payments data shows 17 records totaling $141. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has moved sharply higher in recent years, from $57,484 to $184,452. Similarly, Part D prescription costs have moved sharply higher in recent years, from $127,762 to $3,972,210. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Part B Carrier Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: Tot_Mdcr_Pymt_Amt. Source: Medicare Physician & Other Practitioners by Provider.0$92K$184K2015 Medicare payment: $57,484 (USD; Tot_Mdcr_Pymt_Amt)2016 Medicare payment: $57,229 (USD; Tot_Mdcr_Pymt_Amt)2017 Medicare payment: $54,784 (USD; Tot_Mdcr_Pymt_Amt)2018 Medicare payment: $53,681 (USD; Tot_Mdcr_Pymt_Amt)2019 Medicare payment: $53,442 (USD; Tot_Mdcr_Pymt_Amt)2020 Medicare payment: $46,535 (USD; Tot_Mdcr_Pymt_Amt)2021 Medicare payment: $68,447 (USD; Tot_Mdcr_Pymt_Amt)2022 Medicare payment: $110,661 (USD; Tot_Mdcr_Pymt_Amt)2023 Medicare payment: $132,111 (USD; Tot_Mdcr_Pymt_Amt)2024 Medicare payment: $184,452 (USD; Tot_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClm LinesPayment
20153651,636$57,484
20163741,717$57,229
20173991,742$54,784
20184361,465$53,681
20194161,522$53,442
20203591,770$46,535
20213692,215$68,447
20226914,009$110,661
20237684,811$132,111
20246826,118$184,452

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Part D Events Trend. X-axis: year 2015-2024. Y-axis: Drug cost, unit: USD. Field: Tot_Drug_Cst. Source: Medicare Part D Prescribers by Provider.0$2.0M$4.0M2015 Drug cost: $127,762 (USD; Tot_Drug_Cst)2016 Drug cost: $173,846 (USD; Tot_Drug_Cst)2017 Drug cost: $510,498 (USD; Tot_Drug_Cst)2018 Drug cost: $611,944 (USD; Tot_Drug_Cst)2019 Drug cost: $701,585 (USD; Tot_Drug_Cst)2020 Drug cost: $668,011 (USD; Tot_Drug_Cst)2021 Drug cost: $1,372,228 (USD; Tot_Drug_Cst)2022 Drug cost: $2,334,340 (USD; Tot_Drug_Cst)2023 Drug cost: $3,643,775 (USD; Tot_Drug_Cst)2024 Drug cost: $3,972,210 (USD; Tot_Drug_Cst)2015201620172018201920202021202220232024
YearPatientsClaimsDrug Cost
20152411,991$127,762
20162832,205$173,846
20172982,442$510,498
20182912,285$611,944
20192592,023$701,585
20202581,809$668,011
20212611,910$1,372,228
20224862,952$2,334,340
20236794,269$3,643,775
20246884,178$3,972,210

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

DME Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: DME_Suplr_Mdcr_Pymt_Amt. Source: Medicare DME, Devices & Supplies by Referring Provider.0$737$1.5K2017 Medicare payment: $1,473 (USD; DME_Suplr_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClaimsPayment
2015N/RN/RN/R
2016N/RN/RN/R
2017N/R14$1,473
2018N/RN/RN/R
2019N/RN/RN/R
2020N/RN/RN/R
2021N/RN/RN/R
2022N/RN/RN/R
2023N/RN/RN/R
2024N/RN/RN/R

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

CodeDescriptionPatientsClm LinesTotal Payment
90677Pneumococcal conjugate vaccine, 20 valent (pcv20), for intramuscular use6969$286
99214Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more433696$83
20610Aspiration and/or injection of fluid from large joint6384$50
77080Dxa bone density measurement of hip, pelvis, spine220220$9
J3301Injection, triamcinolone acetonide, not otherwise specified, 10 mg76489$1

Top 5 Part D drugs in 2024

By total drug costs.

DrugGenericClaimsTotal Day SupplyTotal Drug Cost
Enbrel SureclickEtanercept1825,544$1,477,301
Humira(Cf) PenAdalimumab882,688$665,411
RinvoqUpadacitinib371,110$238,489
XeljanzTofacitinib Citrate271,350$233,611
Enbrel MiniEtanercept25700$180,547

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

CategoryDefinitionRecordsTotal Reported AmountTop Related Entity
General PaymentsReported payment or transfer-of-value amount.17$141ABBVIE INC.
Research PaymentsReported research-related payment or transfer-of-value amount.0$0N/R
Ownership / Investment InterestsReported value of ownership or investment interests.0$0N/R

FAQ

What Medicare data is available for Malarvizhi Natarajan, MD?

Tedicare shows public-source Medicare data for Malarvizhi Natarajan, MD (NPI 1306022868), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Malarvizhi Natarajan, MD have ACO affiliation data?

Malarvizhi Natarajan, MD is shown with ACO affiliation data for Franciscan ACO, Inc. (MSSP, ACO ID A2550), Ascension Care Management (MSSP, ACO ID A2600), IRCCO (MSSP, ACO ID A2619), Main Street Rural Health Cedar ACO LLC (MSSP, ACO ID A5502), and Indiana University Health ACO, Inc. (REACH, ACO ID D0034).

What billing organization is linked to Malarvizhi Natarajan, MD?

Malarvizhi Natarajan, MD is linked to ARNETT CLINIC, LLC (billing NPI 1164490843) in the available physician profile data.

Does Malarvizhi Natarajan, MD have Open Payments data?

Malarvizhi Natarajan, MD has 17 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.